Zobrazeno 1 - 3
of 3
pro vyhledávání: '"James M. Woolven"'
Autor:
Christopher R. Wellaway, Ian R. Baldwin, Paul Bamborough, Daniel Barker, Michelle A. Bartholomew, Chun-wa Chung, Birgit Dümpelfeld, John P. Evans, Neal J. Fazakerley, Paul Homes, Steven P. Keeling, Xiao Q. Lewell, Finlay W. McNab, Joanne Morley, Deborah Needham, Margarete Neu, Antoon J. M. van Oosterhout, Anshu Pal, Friedrich B. M. Reinhard, Francesco Rianjongdee, Craig M. Robertson, Paul Rowland, Rishi R. Shah, Emma B. Sherriff, Lisa A. Sloan, Simon Teague, Daniel A. Thomas, Natalie Wellaway, Justyna Wojno-Picon, James M. Woolven, Diane M. Coe
Publikováno v:
Journal of Medicinal Chemistry. 65:633-664
The Janus family of tyrosine kinases (JAK1, JAK2, JAK3, and TYK2) play an essential role in the receptor signaling of cytokines that have been implicated in the pathogenesis of severe asthma, and there is emerging interest in the development of small
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25612a371cd9b4befcdd69bdbd64fbaa
https://doi.org/10.1021/acs.jmedchem.1c01765
https://doi.org/10.1021/acs.jmedchem.1c01765
Autor:
Lee A, Harrison, Stephen J, Atkinson, Anna, Bassil, Chun-Wa, Chung, Paola, Grandi, James R J, Gray, Etienne, Levernier, Antonia, Lewis, David, Lugo, Cassie, Messenger, Anne-Marie, Michon, Darren J, Mitchell, Alex, Preston, Rab K, Prinjha, Inmaculada, Rioja, Jonathan T, Seal, Simon, Taylor, Ian D, Wall, Robert J, Watson, James M, Woolven, Emmanuel H, Demont
Publikováno v:
Journal of medicinal chemistry. 64(15)
Domain-specific BET bromodomain ligands represent an attractive target for drug discovery with the potential to unlock the therapeutic benefits of antagonizing these proteins without eliciting the toxicological aspects seen with pan-BET inhibitors. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::29838ca81add590d8ccf661d7c0b5e04
https://pubmed.ncbi.nlm.nih.gov/34232650
https://pubmed.ncbi.nlm.nih.gov/34232650
Autor:
James M. Woolven, William J. Kerr, Chun-wa Chung, Bhumika Karamshi, Beata S. Wyspiańska, John Evans, Emmanuel Hubert Demont, Laurie Gordon, Matthew J Lindon, Peter E. Soden, Rob Willis, Leanne Cutler, Darren J. Mitchell, Christopher Roland Wellaway, Antonia J. Lewis, Robert J. Watson, Paul Bamborough, Simon Taylor, Inmaculada Rioja, Sharon G. Bernard, Rab K. Prinjha, Peter D. Craggs
The bromodomain and extraterminal domain (BET) family of epigenetic regulators comprises four proteins (BRD2, BRD3, BRD4, BRDT), each containing tandem bromodomains. To date, small molecule inhibitors of these proteins typically bind all eight bromod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2071ff9f599969eeda5e1e32f456446
https://strathprints.strath.ac.uk/73542/1/Wellaway_etal_JMC_2020_Structure_based_design_of_a_bromodomain_and_extraterminal_domain_BET_inhibitor.pdf
https://strathprints.strath.ac.uk/73542/1/Wellaway_etal_JMC_2020_Structure_based_design_of_a_bromodomain_and_extraterminal_domain_BET_inhibitor.pdf
